Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Blueberries Medical Corp. (C:BBM)

Business Focus: Cannabis Product Retailers

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for BBM within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Aug 25, 2022 17:50 ET
Blueberries Medical Reports 2022 Q2 Financial Results and Provides Corporate and Operations Update
Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together...
Read full article
Jul 29, 2022 09:19 ET
Blueberries Medical Announces the launch of new markets for its products, partnerships in agronomic operation and the Extension of Maturity Date of Convertible Debenture
Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces that has achieved several CBD and non-psychoactive...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
1.68
--
--
Price to Sales - TTM
37.57
5.23
5.50
Price to Book - most recent quarter
17.01
1.55
1.89
Price to Cash Flow per share - TTM
--
14.70
11.88
Price to Free Cash Flow per share - TTM
--
--
16.33
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 2022228,463224,435
Aug 31, 20224,028-6,038
Aug 15, 202210,066-23,929
See Short Report

Business Summary

Sector:  Consumer Non-Cyclicals Industry:  Drug Retailers

Blueberries Medical Corp. (Blueberries) is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the cultivation and development of medicinal cannabis and related products. The Company is specialized in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries also licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis.

See business summary

 

Twitter

Search (past week) for $BBM.CA

  • No tweets found